"CHEM_NA" "COMMON_NA" "SYMBOL" "GROUP_NA" "FORMULA_C" "FORMULA_H" "FORMULA_O" "FORMULA_N" "FORMULA_P" "FORMULA_S" "MOL_WT" "STR_1" "STR_2" "STR_3" "STR_4" "STR_5" "STR_6" "STR_7" "STR_8" "STR_9" "STR_10" "STR_11" "REF_STR" "MELT_PT" "BOIL_PT" "OPT_ROT" "REFRA_IND" "DENSITY" "SOLUBILITY" "REF_PRP" "UV_SPEC" "IR_SPEC1" "NMR_SPEC1" "MS_SPEC1" "NOTE_SPEC" "REF_SPC" "SOURCE" "REF_SOU" "BIOL_ACTIV" "REF_BA" "NOTE1" "REF_NOTE" "SYNTHETIC SPHINGOSYLPHOSPHORYLCHOLINE-PROTEIN CONJUGATE" 23.00 50.00 5.00 2.00 1.00 0.00 " O" " ‖ (+) (REF:005)" " CH3-(CH2)14-CH-CH-CH2-O-P-O-(CH2)2-N(CH3)3" " ｜ ｜ ｜" " OH NH O-" " ｜" " CO ｮｴ＼" " ｜ ｳ" " ｸ／ｨN=N-ALBUMIN" "005/" "280nm PROTEIN由来，360-370nm DIAZOPHENYL由来 (005)" "005/" "抗原 抗スフィンゴミエリン抗体の産生と PASSIVE CUTANEOUS ANAPHYLAXIS による解析" "SPHINGOSYLPHOSPHORYLCHOLINE (D-ERYTHRO AND L-THREO ISOMERS)" "LYSOSPHINGOMYELIN" 23.00 48.00 5.00 2.00 1.00 0.00 " O CH3 (REF:009/010)" " ‖ ｜" " CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-(CH2)2-N(+)-CH3" " ｜ ｜ ｜ ｜" " OH NH2 O(-) CH3" "009/010/" "OPTICAL ROTAORY DISPERSION (ORD)で NEGATIVE PATTERN ( スフィンゴミエリンは POSITIVE) (009)" "009/" """13C-NMR (DEPT) (010) SPHINGOSINE C1=63.63, C2=57.24, C3=69.84, C4=137.18, C5=127.98, C6=32.60, C7-C15=30.14-29.47, C16=32.40, C17=23.10, C18=14.21 ppmPHOSPHOCHOLINE C1=66.92, C2=60.05, C3=54.49 ppm""" "FAB MASS SPECTRA: スフィンゴミエリンのアミド結合の開裂は，D-ERYTHRO型の方がL-THREO型より容易に起きる． (009)" "009/010/" "1-o-OCTADECYL-2-AZELAORYLGLYCEROPHOSPHOCHOLINE" 35.00 70.00 9.00 1.00 1.00 " O CH2O-(CH2)17-CH3 (REF:015)" " ｾ |" "HOOC-(CH2)7-C-O-CH O CH3" " | ｾ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "015/" "JNM-GX400 FOURIER TRANSFER NMRによって1-0-OCTADECYL-2-LINOLEOYLGLYCERO- PHOSPHOCHOLINEと比較(015)" "SI-MSおよびFAB-MSで分子量を測定。またジアゾメタンでカルボン酸をメチル化すると分子量が679->693に14増加することを確認(015)" "015/" "ホスファチジルコリンのオキシヘモグロビンによる酸化産物(015/016/017)" "015/016/017/" "赤血球を溶血させる(015/016)． 赤血球アセチルコリンエステラーゼ活性を低下させる(015/016)" "015/016/" "3-SN-PHOSPHATIDYLSERINE PHOSPHATIDYLSERINE" """PHOSPHATIDYLSERINE, SERINE PHOSPHOGLYCERIDE""" "PS" "GO" 42.00 82.00 10.00 1.00 1.00 0.00 0.00 "CH2-O-CO-R (DISTEAROYL) (REF:001/002)" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH-COOH" "| | R-CO- ACYL基" "OH NH2 R'-CO-" "001/002/" "159 - 161 (DISTEAROYL) (003)" "[α]20/D= -14.0(DISTEAROYL)(IN CHLOROFORM) (003)" """PRACTICALLY INSOL. IN WATER, SLIGHTLY SOLUBLE IN BENZENE,CHLOROFORM (003)""" "003/" "紫外部吸収はない" """3430-3230(SALT-FORM), 2780-2630(ACID-FORM), 1250-2220, 1175-1160, 1110-1090(SALT-FORM),1070-1055,1040-1000(ACID-FORM) IN CCl4 P-OH(1075-1050)がPO(-)(1100)よりも強い吸収(004)""" """重水素ﾗﾍﾞﾙされたDIOLEOYL,DIMYRISTOYL,DIPALMITOYL PSを合成して 360MHz 1H NMRを測定(005)""" "004/005/" "動物組織(006/007)，植物組織(008/009)，藻類(008/009)，酵母(010)，かび(011/012)，細菌(013/014)，被膜ウイルス(015/016)" "006/007/008/009/010/011/012/013/014/015/016/" "生体膜構成成分，肥満細胞からのﾋｽﾀﾐﾝの遊離に関与（促進）(017)，ﾓﾙﾋﾈ類の受容 体としての関与(018)，蛋白質燐酸化酵素ＣのCOFACTORとして細胞の刺激受容機構に関与(019/ 020)，血液凝固への関与(021/022/023)，膜結合性酵素(Na(+)- K(+)-ATPase(024))の発現に関与(025)" "017/018/019/020/021/022/023/024/025/" """3-SN-PHOSPHATIDYLETHANOLAMINE, PHOSPHATIDYLETHANOLAMINE""" """PHOSPHATIDYLETHANOLAMINE, ETHANOLAMINE PHOSPHOGLYCERIDE""" "PE" "GO" 41.00 82.00 8.00 1.00 1.00 0.00 0.00 "CH2-O-CO-R (DISTEAROYL) (REF:026)" "|" "R'-CO-O-CH O" "| ‖ R-CO- ACYL基" "CH2-O-P-O-CH2-CH2-NH2 R'-CO-" "|" "OH" "026/" "180 - 182 (DISTEAROYL) (003)" "[α]20/D= +6.0(DISTEAROYL) IN CHLOROFORM-ACETIC ACID(1:1) (003)" """PRACTICALLY INSOL.IN WATER,ACETONE,PETR ETHER,ETHER,SLIGHTLY SOL IN EtOH, BENZENE,CCl4, FREELY SOL IN CH3Cl(003)""" "003/" "紫外部吸収はない．" "IR SPECTRA OF VARIOUS PE 4000-250cm-1(028/027)" """PE, O-PHOSPHORYLETHANOLAMINE L-α-GLYCEROPHOSPHORYLETHANOLAMINEの1H,31P NMRの測定による極性基の立体配位に関する研究(029)""" "028/027/029/" "動物組織(006/007)，植物組織(008/009)，藻類(010)，かび(011/012)，細菌(013/014)，被膜ウイルス(015/016)" "006/007/008/009/010/011/012/013/014/015/016/" """生体膜構成成分，構成脂肪酸中の多価不飽和脂肪酸はﾌﾟﾛｽﾀﾉｲﾄﾞの前駆物質(030)， 細胞膜流動性への関与，膜結合性酵素(GLUCOSE-6-PHOSPHATE(031),UDP-GALACTOSE- LIPOPOLYSACCHARIDES GALACTOSYLTRANSFERASE(032),RHODOPSIN(033))の活性発現に関与(025)""" "030/031/032/033/025/" "1-O-9'-CIS-OCTADECENYL-2-O-OCTADECANOYL-SN-GLYCEROL-3-PHOSPHOETHANOLAMINE" 41.00 82.00 7.00 1.00 1.00 0.00 731.00 " O CH2-O-(CH2)8-CH=CH-(CH2)7-CH3 (REF: )" " ‖ |" "CH3-(CH2)16-C-O-CH O" " | ‖" " CH2-O-P-O-CH2-CH2-NH2" " |" " OH" "192-293" "[α]22/D=3.1(39mg/ml IN HEXANE)" "本品は合成品であるが(003)，天然ではウシ赤血球から1-0-ALKYL-2-ACYL-GPEを得ている(004)" "003/004/" "1-O-CIS-9'-OCTADECENYL-2-O-OCTEDECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE" 44.00 88.00 7.00 1.00 1.00 0.00 773.00 " O CH2-O-(CH2)8-CH=CH-(CH2)7-CH3 (REF: )" " ‖ |" "CH3-(CH2)16-C-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " OH CH3" "232 (003)" "[α]22/D=2.6(18mg/ml IN CHCl3-MeOH(1:1)) (003)" "003/" """-CH3:,-CH2:2920,2850,1460,1370cm-1, CIS DOUBLE BOND:3000cm-1, P-O-:108cm-1,P=O:1230cm-1, -OH(H2O):NEAR 3330cm-1, P-O-C:1050,950cm-1, C-O-C:1110cm-1 SHOULDER, C=O:1725cm-1""" "本物質は合成品であるが，1-0-ALKYL-2-ACYL-GPCは多くの動物臓器や細胞に存在す る (005)． PAFの前駆体と考えられている．" "005/" """1,2-DI-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE""" 44.00 94.00 6.00 1.00 1.00 0.00 763.00 " CH2-O-(CH2)17-CH3 (REF:006)" " |" "CH3-(CH2)17-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "006/" "201-202" """[α]22/D=1.3(C,4) (IN CHCl3:MeOH(1:1))""" """1,2位がOCTADECYLの合成は文献(002)に記載されている．""" "002/" """1,2-DI-O-CIS-9'-OCTADECENYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE""" 41.00 84.00 6.00 1.00 1.00 0.00 717.00 " CH2-O-(CH2)8-CH=CH-(CH2)7-CH3 (REF: )" " |" "CH3-(CH2)7-CH=CH-(CH2)8-O-CH O" " | ‖" " CH2-O-P-O-CH2-CH2-NH2" " |" " OH" "180-181 (003)" "[α]22/D=1.7(50mg/ml IN CHCl3-MeOH(1:1)) (003)" "003/" """-CH3,-CH2:2920,2850,1460,1370cm-1, P-OH:1025cm-1, P-O-C:1060cm-1, P-O(-):1210cm-1, CIS DOBLE BOND:3000cm-1, -C-O-C:1110cm-1 SHOULDER N-H:1620cm-1""" "1-O-HEXADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE" "PLATELET ACTIVATING FACTOR" "PAF" 26.00 54.00 5.00 1.00 1.00 0.00 491.00 " O CH2-O-(CH2)15-CH3 (REF: )" " ‖ |" "CH3-C-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "ｸﾞﾘｾﾙｴｰﾃﾙをｲｿﾌﾟﾛﾋﾟﾘｼﾞﾝ化してGC/MS(008) NATIVE PAFのFD-MA(008)" "008/" "ヒト白血球(007)，マクロファージ(007)，マスト細胞(007)，胎児肺(007)，ヒト血 管内皮細胞(007)，ウサギ好塩基球(008)．" "007/008/" "血小板活性化作用． 好中球，単球活性化作用． 血管透過性亢進作用．平滑筋収縮作用 血圧降下作用． グリコーゲン分解促進作用．１位がHEXADECYLの場合が最も活性が強い．" "1-O-OCTADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE" "PLATELET ACTIVATING FACTOR" "PAF" 28.00 58.00 5.00 1.00 1.00 0.00 519.00 " O CH2-O-(CH2)17-CH3 (REF: )" " ‖ |" "CH3-C-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "ヒト白血球(007)，マクロファージ(007)，マスト細胞(007)，胎児肺(007)，ヒト血 管内皮細胞(007)，ウサギ好塩基球(008)．" "007/008/" "血小板凝集作用． 好中球，単球活性化作用． 血管透過性亢進作用．平滑筋収縮作用 血圧降下作用． グリコーゲン分解促進作用．血小板凝集作用は１位がHEXADECYLの場合の約1/4である．" "1-O-(9'-CIS-OCTADECENYL)-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE" "PLATELET ACTIVETING FACTOR" 28.00 56.00 5.00 1.00 1.00 0.00 517.00 " O CH2-O-(CH2)8-CH=CH-(CH2)7-CH3 (REF: )" " ‖ |" "CH3-C-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "ヒト白血球(007)，マクロファージ(007)，その他多くの免疫関連細胞で産生．" "007/" "血小板凝集作用(007)． 好中球，単球活性化作用． 血管透過性亢進作用．平滑筋収縮作用． 血圧降下作用． グリコーゲン分解促進作用．血小板凝集作用は１位がHEXADECYLの場合の約1/2である．" "007/" "1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE" 23.00 50.00 6.00 1.00 1.00 0.00 467.00 " CH2-(CH2)17-CH3 (REF: )" " |" "HO-CH O" " | ‖" " CH2-O-P-O-CH2-CH2-NH2" " |" " OH" """BATYL ALCOHOLのDIACETATEとして:2935,2870cm-1:CH3,CH2,CH STRETCH, 1739cm-1:ESTER C=O, 1465cm-1:-CH2-DEFORMATION, 1375cm-1:C-CH3 DEFORMATION 1230cm-1:C-O- STRETCH ACETATE, 1116cm-1:-CH2-O-CH3""" "ニワトリ卵黄(010)，但し卵黄中にあるときは2位はアシル化されているものと思わ れる．" "1-HEXADEC-1'-ENYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE" "ETHANOLAMINE PLASMALOGEN" 39.00 73.00 7.00 1.00 1.00 0.00 698.00 " O CH2-O-CH=CH-(CH2)13-CH3 (REF: )" " ‖ |" "CH3-(CH2)4-CH=CH-CH2-CH=CH-(CH2)7-C-O-CH O" " | ‖" " CH2-O-P-O-CH2-CH2-NH2" " |" " OH" "肝を除く動物の殆どの臓器に存在する(011)，特に脳，心臓，筋肉，睾丸に多い．" "011/" "不明" "1-O-HEXADEC-1'-ENYL-2-LINOLEOYL-SN-GLYCEROL-3-PHOSPHOCHOLINE" "CHOLINE PLASMALOGNE" 42.00 79.00 7.00 1.00 1.00 0.00 740.00 " O CH2-O-CH=CH-(CH2)13-CH3 (REF: )" " ‖ |" "CH3-(CH2)4-CH=CH-CH2-CH=CH-(CH2)7-C-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "ﾃﾞｰﾀNo20にMASSの図有り（2位はｱﾗｷﾄﾞﾝ酸）" "ウシ脳(011)，心臓(011)，筋肉(011)，睾丸(011)． ラット肝にはほとんどないが，肝以外の臓器には多く含まれている．" "011/" "多くの活性が提案されているが，明確なものはない．" "1-O-HEXADEC-1'-ENYL-2-ACTYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE" 23.00 46.00 5.00 1.00 1.00 0.00 447.00 " O CH2-O-CH=CH-(CH2)13-CH3 (REF: )" " ‖ |" "CH3-C-O-CH O" " | ‖" " CH2-O-P-O-CH2-CH2-NH2" " |" " OH" "ヒト末梢血白血球（A-23187で刺激したとき）(012)．" "012/" "不明．" "1-O-HEXADEC-1'-ENYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE" "ALKENYL PAF" 26.00 52.00 5.00 1.00 1.00 0.00 489.00 " O CH2-O-CH=CH-(CH2)13-CH3 (REF:013)" " ‖ |" "CH3-C-O-CH O CH3" " | ‖ |(+)" " CH2-O-P-O-CH2-CH2-N-CH3" " | |" " O(-) CH3" "013/" """EI-MS,FB=MSが図示(013)""" "013/" "天然にまだ見いだされていない．" "1-16:0 PAFの血小板凝集活性の1/5の活性が存在" "CALDERCHAETIDYLSERINE" 89.00 178.00 11.00 1.00 1.00 0.00 1467.00 " CH3 CH3 CH2--O" " | | | |" " HCH-O-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-O-CH O=P-O-HCH" " | CH3 CH3 | | | | |" " | | | CH3 CH3 | OH |" " CH-O-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-O-CH2 HOOC-CH" " | | | |" "HO-CH2 CH3 CH3 H2N" " (REF:016)" "016/" """1467[M](-),1379[M-CH2CHNH3COO](-),1378[M-CH2CHNH3COO-1](-) IN NATIVE ION FAB-MS(016)""" "016/" """ARCHAEBACTERIUM, METHANOBACTERIUM THERMOAUTOTROPHICUM(016)に存在""" "016/" "不明" "GENTIOBIOSYLCALDARCHAETIDYLINOSITOL" 104.00 203.00 24.00 0.00 1.00 0.00 1866.00 " CH3 CH3 CH2--O" " | | | |" " HCH-O-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-O-CH O=P-O-Ins" " | CH3 CH3 | | | |" " | | | CH3 CH3 | OH" " CH-O-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-{CH-(CH2)3}3-CH-(CH2)2-O-CH2" " | | |" " CH2 CH3 CH3" " |" " O-1βGlc6-1βGlc (REF:016)" "016/" "[α]22/D=-9.2 INOSITOL 1-Pの旋光度(FREE FORM)" """NATIVE ION FAB-MS(016): m/e=1866[M](-), 1703[M-C6H11O5](-), 1702[M-C6H11O5-1](-), 1541[M-C12H21O10](-), 1540[M-C12H12O10-1](-)""" "016/" """ARCHAEBACTERIUM, METHANOBACTERIUM THERMOAUTOTROPHICUM(016)に存在""" "016/" "不明" """2,3-DI-O-[3',7',11',15'-TETRAMETHYLHEXADECYL]-SN-GLYCERO-1-PHOSPHORYL-1''- GLYCERO-3''-PHOSPHATE""" 46.00 96.00 11.00 0.00 2.00 0.00 886.00 " O" " ‖" " CH3 CH3 CH2-O-P−CH2" " | | | | |" "CH3-{CH-(CH2)3}3-CH-(CH2)2-O-CH O OH-CH O" " CH3 CH3 | (-) | ‖" " | | | CH2-O-P-O(-)" "CH3-{CH-(CH2)3}3-CH-(CH2)2-O-CH |" " O(-)" " (REF:017)" "017/" "[α]22/D=7.8 (このｸﾞﾘｾﾘﾝはL-TYPEであるとしている)" """3300cm-1:HYDROGEN BONDのOH,2940,2860,1465cm-1:GEN-DIMETHYL AND C-CH3 GROUPS1260,1230cm-1:P=O,1055cm-1:P-O-C,1730cm-1:C=Oはない(017)""" "ALKYL IODIDEのNMRが測定されてC20COMPOUNDでC-CH3が4つあることが確認されてい る(017)" "017/" """HALOPHILIC BACTERIUM, HALOBACTERIUM CUTIRUBRUM(017)に存在""" "017/" "不明" """1,2-DI-O-ACYL-SN-GLYCERO-(3)-PHOSPHATE""" "2-PHOSPHATIDIC ACID" "PA" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-CO-R" "|" "R'-CO-CH-H O" "| ‖" "CH2-O-P-OH" "|" "OH" "動物組織(003)昆虫(008)，植物(009)，カビ(010)，細菌(011)" "003/008/009/010/011/" "全てのグリセロリン脂質の前駆体" "1-ACYL-SN-GLYCERO-(3)-PHOSPHATE" "LYSOPHOSPHATIDIC ACID" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "HO-C-H O" "| ‖" "CH2-O-P-OH" "|" "OH" "1-ACYLGLYCEROLのリン酸化(016)，lysolecithinのphospholypaseD処理(017)" "016/017/" "アシルトタンスフェラ−ゼ受容体" "2-ACYL-SN-GLYCERO-(3)-PHOSPHATE" "LYSOPHOSPHATIDIC ACID" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-OH" "|" "R'-CO-O-CH-H O" "| ‖" "CH2-O-P-OH" "|" "OH" "1-ACYLGLYCEROLのリン酸化(016)，lysolecithinのphospholypaseD処理(017)" "016/017/" "アシルトタンスフェラ−ゼ受容体" "1-ALKENYL-2-ACYL-SN-GLYCERO-(3)-PHOSPHATE" "PLASMENIC ACID" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH=CH-R (REF:002)" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-OH" "|" "OH" "002/" "肝臓(020)，脳(022)，Ehrlichがん細胞(021)，コリンプラスマロ−ゲンをホスホリパ-ゼ処理(014)" "020/022/021/014/" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHOCHOLINE""" "LECITHIN 1-A-LECITHIN" "PC" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R (REF:002)" "|" "R'-CO-O-CH O CH3" "| ‖ +|" "CH2-O-P-O-CH2-CH2-N-CH3" "| |" "OH CH3" "002/" """動植物に広く分布(025/026),Hyphomicrobium,Brucella,Nocardia,Rhodopseudomonas(024)""" "025/026/024/" "卵黄レシチン，合成レシチンの物性(037/038)" "037/038/" "2-ACYL-1-(1-ALKENYL)-SN-GLYCERO-(3)-PHOSPHOCHOLIN" """CHOLINPLASMALOGEN, PLASMENYLCHOLIN""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH=CH-R (REF:002/039)" "|" "R'-CO-O-CH O CH3" "| ‖ +|" "CH2-O-P-O-CH2-CH2-N-CH3" "| |" "OH CH3" "002/039/" "心筋(041/042)，精液(042)，神経系(043)，血しょう，血球(044)" "041/042/043/044/" "脂肪酸組成，ｱﾙﾃﾞﾋﾄﾞ組成(045/047)，総説(040)" "045/047/040/" "2-ACYL-1-(1-ALKYL)-SN-GLYCERO-(3)-PHOSPHOCHOLIN" "PLASMANYLCHOLIN" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH2-CH2-R" "|" "R'-CO-O-CH O CH3" "| ‖ +|" "CH2-O-P-O-CH2-CH2-N-CH3" "| |" "OH CH3" "Tertahymena(051)，ナメクジ(052)，Ehrkich癌細胞(053)，ウサギ筋小胞体(054)" "051/052/053/054/" "総説(048/049/050)" "048/049/050/" "1-DIACYL-SN-GLYCERO-(3)-PHOSPHOCHOLINE" """LYSOLECITHIN ,LYSOPHOSPHATIDYLCHOLINE""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "HO-CH O CH3" "| ‖ +|" "CH2-O-P-O-CH2-CH2-N-CH3" "| |" "OH CH3" "組織のリン脂質の1-5%を占める(025)，ウシ甲状腺クロマフィン顆粒(056)" "025/056/" "総説（細胞融合誘導，溶血性，酵素活性化，界面活性）(029/058) 脂肪酸組成(057)" "029/058/057/" "2-DIACYL-SN-GLYCERO-(3)-PHOSPHOCHOLINE" """LYSOLECITHIN ,LYSOPHOSPHATIDYLCHOLINE""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-OH" "|" "R-CO-O-CH O CH3" "| ‖ +|" "CH2-O-P-O-CH2-CH2-N-CH3" "| |" "OH CH3" "天然界に存在しない(059/060)" "059/060/" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHOSERINE""" "PHOSPHATIDYLSERINE" "PS" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-CO-R (REF:002)" "|" "R'-CO-O-CH O NH2" "| ‖ |" "CH2-O-P-O-CH2-CH-COOH" "|" "OH" "002/" "動物組織に多く(025)，植物に少ない(002)，細菌(011/012)" "025/002/011/012/" "生物活性(086)" "086/" "1-ALKENYL-2-ACYL-SN-GLYCEROPHOSPHO-L-SERINE" "SERINEPLASMALOGEN" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH=CH-R" "|" "R'-CO-O-CH O NH2" "| ‖ |" "CH2-O-P-O-CH2-CH-COOH" "|" "OH" "脳(083)，血球(084/085)" "083/084/085/" "1-ALKYL-2-ACYL-SN-GLYCEROPHOSPHO-L-SERINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH2-CH2-R" "|" "R'-CO-O-CH O NH2" "| ‖ |" "CH2-O-P-O-CH2-CH-COOH" "|" "OH" "1-ACYL-SN-GLYCERO-(3)-PHOSPHOSERINE" "LYSOPHOSPHATIDYLSERINE" "lysoPS" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "HO-CH O NH2" "| ‖ |" "CH2-O-P-O-CH2-CH-COOH" "|" "OH" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHOETHANOLAMINE""" """PHOSPHATIDYLETHANOLAMINE,CEPHARINE""" "PE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R (REF:002)" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH2" "|" "OH" "002/" """総説（動物，植物，細菌に広く分布)(062/063)，lecithinについで多い 卵黄(063)，ダイズ(064),大腸菌(065)""" "062/063/064/065/" "水に懸濁するとヘキサゴナル相をとり，ラメラ相をとらない(063/066)" "063/066/" "2-ACYL-1-(1-ALKENYL)-SN-GLYCERO-(3)-PHOSPHOETHANOLAMINE" "ETHANOLAMINEPLASMALOGEN" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH=CH-R (REF:039/002)" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH2" "|" "OH" "039/002/" "総説(040)，脳の白質（特にミエリン），心筋" "脂肪酸組成(067)" "067/" "1-ALKYL-2-ACYL-SN-GLYCERO-(3)-PHOSPHOETHANOLAMINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH2-CH2-R" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH2" "|" "OH" "脳(068)，骨髄(069)，Ehrlich癌細胞(053)，ナメクジ(052)，Tetrahymena(051)" "068/069/053/052/051/" "脂肪酸組成(050)" "050/" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHO-N-(2-HYDROXYL)-ALANINE""" "PHOSPHATIDYL-N-(2-HYDROXYL)-ALANINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-CO-R (推定構造）" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH-CH-CH3" "| |" "OH COOH" "Entodinium caudatum( )" "1-DIACYL-SN-GLYCERO-(3)-PHOSPHOETHANOLAMINE" """LYSOPHOSPHATIDYLETHANOLAMINE,""" "lysoPE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "HO-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH2" "|" "OH" "動物組織(071/072/073)，カビ(074)，PEのホスホリパ−ゼ処理(065)" "071/072/073/074/065/" "2-DIACYL-SN-GLYCERO-(3)-PHOSPHOETHANOLAMINE" """LYSOPHOSPHATIDYLETHANOLAMINE,""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-OH" "|" "R-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH2" "|" "OH" "動物組織(071/072/073)，カビ(074)，PEのホスホリパ−ゼ処理(065)" "071/072/073/074/065/" """1,2-DI-ACYL-SN-GLYCERO-(3)-PHOSPHO-N-METHYLETHANOLAMINE""" "N-METHYLPHOSPHTIDYLETHANOLAMINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH-CH3" "|" "OH" """ラット肝臓での代謝中間産物(075/076)，Hemophilus influenzae(076)，酵母(076),Neurospora crassa(077)，Clostridium butyricum(078)，Brucellus abortus Bang (079),化学合成""" "075/076/077/078/079/" """1,2-DI-ACYL-SN-GLYCERO-(3)-PHOSPHO-N,N-DIMETHYLETHANOLAMINE""" """N,N-DIMETHYLPHOSPHTIDYLETHANOLAMINE""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "R'-CO-O-CH O CH3" "| ‖ |" "CH2-O-P-O-CH2-CH2-N-CH3" "|" "OH" """1,2-DI-ACYL-SN-GLYCERO-(3)-PHOSPHO-N-ACYL""" "N-ACYLPHOSPHTIDYLETHANOLAMINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH-CO-R''" "|" "OH" "小麦粉，大豆(194/195)，ピ−ナッツ(095)" "194/195/" """1,2-DI-ACYL-SN-GLYCERO-(3)-PHOSPHO-SN-GLYCEROL""" "PHOSPHATIDYLGLYCEROL" "PG" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-OH" "| |" "R'-CO-O-CH O HO-CH" "| ‖ |" "CH2-O-P-O--CH2" "|" "OH" "植物，細菌に広く分布(089)，ｸﾞﾗﾑ陽性菌(090)，ﾏｲｺﾌﾟﾗｽﾞﾏ(091)，植物葉緑体(092)動物細胞ﾐﾄｺﾝﾄﾞﾘｱに少量存在" "089/090/091/092/" "ｶﾙｼﾞｵﾘﾋﾟﾝの前駆体(094)，糖の能動輸送に関与する酵素の活性発現(095) 脂肪酸組成(093/096)，代謝回転(093)" "094/095/093/096/" """2,3-DIALKYL-SN-GLYCERO-1-PHOSPHO-(3')-SN-GLYCEROL""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O" "‖" "CH2-O-P-O----CH2 R-CH2-O-:PHYTANYL-" "| | |" "R-CH2-O-CH OH HC-OH CH3-CH-CH2-(CH2-CH2-CH-CH2)3-CH2-O-" "| | | |" "CH2-O-CH2-R CH2-OH CH3 CH3" "Halobacterium cutirublum(100/101)" "100/101/" """2,3-PHYTANYL-SN-GLYCERO-1-PHOSPHO-(3')-SN-GLYCEROL-1'-PHOSPHATE""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O" "‖" "CH2-O-P-O-----CH2 R-CH2-O-:PHYTANYL-" "| | | CH3-CH-CH2(CH2-CH2-CH-CH2)3-CH2-O-" "R-CH2-O-CH OH HC-OH O | |" "| | ‖ CH3 CH3" "CH2-O-CH2-R CH2-O-P-OH" "|" "OH" "Halobacterium cutirublum(100/101)" "100/101/" """1,2-DI-ACYL-SN-GLYCERO-(3)-PHOSPHO-1'-SN-GLYCEROL-3'-PHOSPHATE""" "PHOSPHATIDYLGLYCEROLPHOSPHATE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O" "‖" "CH2-O-CO-R CH2-O-P-OH" "| | |" "R'-CO-O-CH O HO-CH OH" "| ‖ |" "CH2-O-P-O---CH2" "|" "OH" "存在の確認（動物，細菌）(102/103/104)，脳，" "102/103/104/" """BIS-(1,2-DIACYL-SN-GLYCERO-3-PHOSPHO)-1',3'-SN-GLYCEROL""" """CARDIOLIPIN 1,3-BIS(SN-PHOSPHATIDYL)GLYCEROL""" "CL" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O" "‖" "CH2-O-CO-R CH2-O-P-O----CH2" "| | | |" "R'-CO-O-CH O HO-CH OH HC-O-CO-R''" "| ‖ | |" "CH2-O-P-O----CH2 CH2-O-CO-R'''" "|" "OH" "動物，植物(092)，細菌に広く分布，動物細胞でﾐﾄｺﾝﾄﾞﾘｱに局在，不飽和酸に富む，牛の心筋(106)，菌体(105)" "092/106/105/" "抗原性(107)，脂肪酸組成(105)" "107/105/" "SN-3-PHOSPHATIDYL-1'-(3'-ACYL)-SN-GLYCEROL" """ACYLPHOSPHITIDYLGLYCEROL,SEMILYSOBISPHOSPHATIDIC ACID""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-CO-R'' (REF:108)" "| |" "R'-CO-O-CH O HO-CH" "| ‖ |" "CH2-O-P-O----CH2" "|" "OH" "108/" """Salmonella typhimurium(108), Mycoplasma(109), E.coli, Niemann-Pick病のﾋﾄ肝 臓(112)，動物組織(110/111)""" "108/109/112/110/111/" "薬物投与による組織への蓄積(113)" "113/" "1-ACYL-SN-3-PHOSPHATIDYL-1'-(3'-ACYL)-SN-GLYCEROL" "LYSOBISPHOSPATIDIC ACID" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-R" "| |" "HO-CH O HO-CH" "| ‖ |" "CH2-O-P-O----CH2" "|" "OH" """Salmonella typhimurium(108), Mycoplasma(109), E.coli, Niemann-Pick病のﾋﾄ肝 臓(112)，動物組織(110/111)""" "108/109/112/110/111/" """1-ACYL-SN-PHOSPATIDYL-1'-PHOSPHOLYL-(2',3'-DIACYL)-SN-GLYCEROL""" """PILOBISPHOSPHATIDIC ACID,BISPHOSPATIDIC ACID""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-CO-R''" "| |" "HO-CH O O HC-O-CO-R'" "| ‖ ‖ |" "CH2-O-P-O-P-O-CH2" "| |" "OH OH" "酵母(114)" "114/" "SN-3-PHOSPHATIDYL-1'-(3'-O-L-LYSINYL)-SN-GLYCEROL" "PHOSPHATIDYLGLYCEROL-O-LYSINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-Lys (REF:024)" "| |" "R'-CO-O-CH O HO-CH" "| ｾ |" "CH2-O-P―O―CH2" "|" "OH" "024/" """Streptococcus faealis(127), Clostridium perfringence(128), Bacillus megaterium(115), Staphylococcus aureus(117), Mycoplasma laidlawii B(119) L-ORNUTINE(120)""" "127/128/115/117/119/120/" "膜構造の維持(126)，倍地のpHと代謝の関係(117/124/125)" "126/117/124/125/" "SN-3-PHOSPHATIDYL-1'-(3'-O-L-ORNITINYL)-SN-GLYCEROL" "PHOSPHATIDYLGLYCEROL-O-ORNITINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-L-Orn (REF:024)" "| |" "R'-CO-O-CH O HO-CH" "| ｾ |" "CH2-O-P―O―CH2" "|" "OH" "024/" """MycobacteriumA,Bacillus cereusB""" "膜構造の維持F，倍地のpHと代謝の関係DG-I" "SN-3-PHOSPHATIDYL-1'-(3'-O-L-ALANYL)-SN-GLYCEROL" "PHOSPHATIDYLGLYCEROL-O-ALANINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-L-Ala" "| |" "R'-CO-O-CH O HO-CH" "| ｾ |" "CH2-O-P―O―CH2" "|" "OH" """Streptpcoccus faecalisAB,Clostridium perfringensC, Mycoplasma laidlawii BDE""" """1-(1,2-DIACYL-SN-GLYCERO-3-PHOSPHO)-2'-O-B-(2-AMINO-2-DEOXY-D-GLUCOPYRANOSYL)-SN-GLYCEROL""" "GLUCOSAMINYLPHOSPHATIDYLGLYCEROL" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-XO-R CH2-OH (REF:116)" "| |" "R'-CO-O-CH O GlcN-O-CH" "| ｾ |" "CH2-O-P― O― CH2" "|" "OH" "116/" "Bacillus megaterium(115/116)" "115/116/" """1-(1,2-DIACYL-SN-GLYCERO-3-PHOSPHO)-3'-O-B-(2-AMINO-2-DEOXY-D-GLUCOPYRANOSYL)-SN-GLYCEROL""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R CH2-O-GlcN (REF:116)" "| |" "R-CO-O-CH O HO-CH" "| ｾ |" "CH2-O-P-O―CH2" "|" "OH" "116/" "Bacillus megaterium(115/116)" "115/116/" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHO-(1)-L-MYO-INOSITOL""" """PHOSPHATIDYLINOSITOL,PHOSPHOINOSITIDE""" """PI, PtdIns""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R (REF:002)" "|" "R'-CO-O-CH O" "| ｾ" "CH2-O-P-O-Ins" "|" "OH" "002/" "全リン脂質の5-10%(012/013/016/130/131/132)，ウシ脳(012)，ウシ肝臓(012)， 植物(009)，細菌(HI，酵母" "012/013/016/130/131/132/009/" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHO-(1)-L-MYO-INOSITOL-4-PHOSPHATE""" """DIPHOSPHOINOSITIDE,PHOSPHATIDYLINOSITOL-4-PHOSPHATE""" "PtdIns4P" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R (REF:002)" "|" "R'-CO-O-CH O" "| ｾ" "CH2-O-P-O-Ins" "| 4" "OH |" "O-PO3H2" "002/" "神経系（特にﾐｴﾘﾝに多い）(025/135/136)，心，肺，肝，血球(138)，酵母(137)" "025/135/136/138/137/" "脂肪酸組成(140)，物性(136)" "140/136/" """1,2-DIACYL-SN-GLYCERO-(3)-PHOSPHO-(1)-L-MYO-INOSITOL-3,4-BISPHOSPHATE""" """TRIPHOSPHOINOSITIDE,PHOSPHATIDYLINOSITOL-3,4-BISPHOSPHATE""" """PtdIns(3,4)P2""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R (REF:002)" "|" "R'-CO-O-CH 0" "| ｾ" "CH2-O-P-O-Ins3-O-PO3H2" "| 4" "OH |" "O-PO3H2" "神経系（特にﾐｴﾘﾝに多い）(025/135/136)，心，肺，肝，血球(138)，酵母(137)" "025/135/136/138/137/" "脂肪酸組成(140)，薬物受容体(141)，物性(136)" "140/135/136/" """1-[1,2-DIACYL-SN-GLYCERO-3-PHOSPHO-2-[O-α-D-MANNOPYRANOSYL]-MYO-INOSITOL""" "PHOSPHATIDYLINOSITOLMONOMANOSIDE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "R'-CO-O-CH" "|" "CH2-O-P-O-Ins" "2" "|" "Manα1" """Micobacterium tuberuclosisBCGB-D，Mycobacterium phleiD，Corynebacterium xerosisE，P.shermaniiF,NocardiaGH,Streptomyces griceusH,Microbispotangium chromogensH,PropionibacteriaI""" "抗原性@" """1-[1,2-DIACYL-SN-GLYCERO-3-PHOSPHO-2-(O-A-D-MANNOPYRANOSYL)-6-O-A-MANNOPYRANOSYL]-MYO-INOSITOL""" "PHOSPHATIDYLINOSITOLDIMANOSIDE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 """Micobacterium tuberuclosisBCGB-D，Mycobacterium phleiD，Corynebacterium xerosisE，P.shermaniiF,NocardiaGH,Streptomyces griceusH,Microbispotangium chromogensH,PropionibacteriaI""" "抗原性@" """1-[1,2-DIACYL-SN-GLYCERO-3-PHOSPHO-2-(O-A-D-MANNOPYRANOSYL)-6-[O-A-MANNOPYRANOSYL-(1-6)-O-A-D-MANNOPYRANOSYL]-MYO-INOSITOL""" "PHOSPHATIDYLINOSITOLTRIMANOSIDE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 """Micobacterium tuberuclosisBCGB-D，Mycobacterium phleiD，Corynebacterium xerosisE，P.shermaniiF,NocardiaGH,Streptomyces griceusH,Microbispotangium chromogensH,PropionibacteriaI""" "抗原性@" """1-[1,2-DIACYL-SN-GLYCERO-3-PHOSPHO-2-(O-A-D-MANNOPYRANOSYL)-6-[O-A-MANNOPYRANOSYL-(1-6)-O-A-D-MANNOPYRANOSYL-(1-6)-O-A-D-MANOPYRANOSYL]-MYO-INOSITOL""" "PHOSPHATIDYLINOSITOLTETRAMANOSIDE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 """Micobacterium tuberuclosisBCGB-D，Mycobacterium phleiD，Corynebacterium xerosisE，P.shermaniiF,NocardiaGH,Streptomyces griceusH,Microbispotangium chromogensH,PropionibacteriaI""" "抗原性@" "N-ACYL-ERYTHRO-SPHINGOSINE-1-PHOSPHOCHOLINE" "SPHINGOMYELIN" "Sph" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O CH3" "‖ +|" "CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-CH2-CH2-N-CH3" "| | | |" "OH NH OH CH3" "|" "CO-R" "動物に広く分布(025)，植物，細菌にない，脳，神経系，血球，腎に多い" "025/" "脂肪酸組成(154)，性質(157)" "154/157/" "N-ACYL-ERYTHRO-SPHINGOSINE-1-PHOSPHOETHANOLAMINE" "CERAMIDEPHOSPHOETHANOLAMINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O" "‖" "CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-CH2-CH2-NH2" "| | |" "OH NH OH" "|" "CO-R" """細菌(158)，イエバエ(159),カ(160)，ヒメタニシ(161)，アコヤガイ(162)， ニワトリ(163) ラット(163)，分布(157)""" "158/159/160/161/162/163/157/" "CERAMIDE-1-PHOSPHO-1'-SN-GLYCEROL" "CERAMIDEPHOSPHOGLYCEROL" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R" "|" "O CH-O-CO-R'" "‖ |" "CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-CH2" "| | |" "OH NH OH" "|" "CO-R'''" """Mycoplasma(165),Bacteroides melaninogenicus(164)""" "165/164/" "CERAMIDE-1-PHOSPHO-1'-SN-GLYCEROL-3'-PHOSPHATE" "CERAMIDEPHOSPHOGLYCEROLPHOSPHATE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-PO3H2" "|" "O CH-O-CO-R" "‖ |" "CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-CH2" "| | |" "OH NH OH" "|" "CO-R''" """Mycoplasma(165),Bacteroides melaninogenicus(164)""" "165/164/" "CERAMIDEPHOSPHOINOSITOL" "CERAMIDEPHOSPHOINOSITOL" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O" "‖" "CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-Ins" "| | |" "OH NH OH" "|" "CO" "|" "R" "トウモロコシ，ダイズ，アマの種子(166)，ラッカセイ(167)" "166/167/" """1,2-DIASYL-SN-GLYCERO-(3)-2-PHOSPHONOETHYLAMINE""" "PHOSPHATIDYLETHYLAMINE" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CO-R (REF:002)" "|" "R'-CO-O-CH O" "| ‖" "CH2-O-P-O-CH2-CH2-NH2" "|" "OH" "002/" """原生動物，Tetrahymena(170/171/172),腔腸動物(173)，軟体動物(174),微生物(175)分布，分離(168/169)""" "170/171/172/173/174/175/168/169/" "脂肪酸組成(176/177)" "176/177/" "CERAMIDEPHOSPHONOETHYLAMINE" "CERAMIDECILIATIN" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O (REF:157)" "‖" "CH3-(CH2)12-CH=CH-CH-CH-CH2-O-P-O-CH2-CH2-NH2" "| | |" "OH NH OH" "|" "CO" "|" "R" "157/" """Bdellovibrio bacteriovorus(179),Tetrahymena(180),ｲｿｷﾞﾝﾁｬｸ(182)，ｾﾀｼｼﾞﾐ(183)ｲｹﾁｮｳｶﾞｲ(184)，ｻｻﾞｴ(185)，ﾀｺ(186)，ｶﾆ(187)，ｳﾆ(188)，繊毛虫(178)""" "179/180/182/183/184/185/187/188/178/" "性質(157)" "157/" "CERAMIDEPHOSPHPONO-N-METHYLETHYLAMINE" "CERAMIDEMETHYLCILIATIN" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "O CH3 (REF:157)" "‖ |" "CH3-(CH2)-CH=CH-CH-CH-CH2-O-P-O-CH2-CH2-N-CH2-CH3" "| | |" "OH NH OH" "|" "CO" "|" "R" "サザエ(185)，イシダタミ(191)，バテイラ(191)，カワニナ(191)，セタシジミ(191)" "185/191/" "構成成分の分析(192/193)" "192/193/" """1,2-DIALKYL-SN-GLYCERO-(3)-PHOSPHOCHOLINE""" 0.00 0.00 0.00 0.00 0.00 0.00 0.00 "CH2-O-CH2-CH2-R" "|" "R''-CH2-CH2-O-CH" "| (+)" "CH2-O-P-O-CH2-CH2-N(CH3)3" """P,P'-BIS-(1,2-DIACYL-SN-GLYCERO-3-)PYROPHOSPHATE""" "PYROPHOSPHATIDIC ACID" "pyro-PA" 78.00 150.00 15.00 0.00 2.00 0.00 1388.00 " CH2-O-CO-R1 (REF:080)" " ｜" " R2-CO-O-C-H O(-) O" " ｜ ｜ ‖ ( R1=R2=R3=R4=C17H35 )" " CH2―O-P-O-P―CH2" " ‖ ｜ ｜" " O O(-)CH―O-CO-R3" " ｜" " CH2-O-CO-R4" "080/" "[α]25/589=+4.70 (IN CHLOROFORM)" """SOLUBLE IN CHLOROFORM, DIETHYLETHER, BENZEN. INSOLUBLE IN METHANOL, ETHANOL, ACETONE,WATER. AT R.T.""" """4000-700 cm-1, THIN FILM ON AgCl PLATE (080)""" """1H-NMR/CDCl3-CD3OD SOLUTION, 31P-NMR/CDCl3-CD3OD SOLUTION (080)""" "080/" """NATURE (085), YEAST (086), MUSHROOM (087/088)""" "085/086/087/088/" "BRAIN PHOSPHOLIPID BIOSYNTHESIS (084)" "084/" "脂肪酸分布 (081)，PYROPHOSPHATIDIC ACID の酵母生育過程での変動 (082)， PYROPHOSPHATIDIC ACID への [32P]放射活性の取り込み (083)， リン脂質分析でのPYROPHOSPHATIDIC ACID の内部標準物質としての利用(089)" "081/082/083/089/" "CERAMIDE 2-AMINOETHYLPHOSPHONATE" "CERAMIDE CILIATINE" 36.00 73.00 5.00 2.00 1.00 0.00 " O (001/002)" " (+) ‖" "H3N-CH2-CH2-P-O-CH2-CH-CH-CH=CH-(CH2)12-CH3" " | | |" " O(-) NH OH" " |" " C=O" " |" " C15H31" "001/002/" "158-159(ｼｼﾞﾐ)" "[α]20/D=12.0" """CHCl3/MeOH,EtOH/ETHERに可溶，ETHER,ACETONE,PYRIDINEに難溶""" """2-AMINOETHYLPHOSPONIC ACIDのIRも示してある．酸ｱﾐﾄﾞ結合の吸収1642,1547,1469 cm-1の吸収と，ﾎｽﾎﾝ酸の吸収1200cm-1が特徴的である(001)""" "001/" "軟体動物，特に貝類(001/003)に多く含まれているが，その他に細菌，原生動物，腔腸動物，節足動物，棘皮動物に分布する． 哺乳動物にも食物連鎖によって取り込まれている(005/006)" "005/006/" "CERAMIDE PHOSPHORYLETHANOLAMINE" "SPHINGOETHANOLAMINE" 36.00 73.00 6.00 2.00 1.00 0.00 " O (007)" " (+) ‖" "H3N-CH2-CH2-O-P-O-CH2-CH-CH-CH=CH-(CH2)12-CH3" " | | |" " O(-) NH OH" " |" " C=O" " |" " C15H31" "007/" "160-162" "[α]20/D=7.3 (IN CHCl3/MeOH) (008)" """CHCl3/MeOH(2:1),ETHER/MeOH(1:1)に昜溶，ACETONE,ETHYL ACETATE,ACETIC ACID, PYRIDINEに難溶""" "008/" """酸ｱﾐﾄﾞ結合に基づく1642,1547,1469 cm-1の吸収,ﾘﾝ基に基づく1250cm-1などが特徴的である．ﾎｽﾎﾝ酸を含むCERAMIDE 2-AMINOETHYLPHOSPHONATEは1200cm-1に吸収端があ るので区別できる(007)""" "007/" """細菌：BACTEROIDES RUMINICOLA(009), BACTEROIDES MELANINOGENICUS(010/011) 原生動物：ENDINIUM CAUDATUM(012) 節足動物：ｲｴﾊﾞｴ(013),ｷﾝﾊﾞｴ(014),ｸﾛﾊﾞｴ(015),ｶ(016)軟体動物：ﾋﾒﾀﾆｼ(007/008),ｱｻﾘ(017),ｱｺﾔｶﾞｲ(018) 脊椎動物：ﾆﾜﾄﾘ(019),ﾗｯﾄ(019)""" "009/010/011/012/013/014/015/016/007/008/017/018/019/" "CERAMIDE 2-MONOMETHYLAMINOETHYLPHOSPHONATE / SERAMIDE 2-(N-METHYLAMINO)ETHYLPHOSPHONATE" 37.00 75.00 5.00 2.00 1.00 0.00 " O (020/021)" " ‖" "CH3-NH-CH2-CH2-P-O-CH2-CH-CH-CH=CH-(CH2)12-CH3" " | | |" " OH NH OH" " |" " C=O" " |" " C15H31" "020/021/" "171.5-172 (020)" "[α]25/D=10.0 (020)" "CHCl3/MeOH(2:1)に昜溶" "020/" "(020/021)" "020/021/" """巻貝(ﾋﾒﾀﾆｼ(020),ｻｻﾞｴ(021))""" "020/021/" "N-METHYL-2-AMINOETHYLPHOSPHONYLGLUCOSYLCERAMIDE" "PHOSPHONOCEREBROSIDE" 45.00 87.00 10.00 2.00 1.00 846.00 " O (REF:039)" " ｾ" " CH3-NH-CH2-CH2-P-O→6Glc-O-CH2-CH-CH-CH=CH-(CH2)8-CH3" " | | |" " OH HN OH" " |" " CO" " |" " C21H41" "039/" """クロロホルム／メタノール(2:1,V/V)に可溶 (039)""" "039/" """OHの3400cm-1の吸収が強い。1640と1550のアミド,1200cm-1のC-P結合の吸収あり。 (039)""" """グルコースのβ結合を示す 4.138と4.102ppmのピークがあり，J1,2は 7.87と8.06Hzである。(039)""" """この糖脂質とそれの部分加水分解物の陰イオン FAB/MSは,分子量とセラミドの質量 を示している。(039)""" "039/" "オキアミ（エビ）(039)" "039/" """1-HEXADECYL-(2)-6,9-OCTADECADIENOYL-SN-GLYCERYL-(3)-2'-AMINOETHYLPHOSPHO- NATE""" "GLYCEROPHOSPHONOLIPID" 39.00 76.00 6.00 1.00 1.00 685.00 " CH2-O-C16H33 (REF:040)" " |" " CH3-(CH2)7-CH=CH-CH2-CH=CH-(CH2)4-CO-OCH O" " | ｾ" " CH2-O-P-CH2-CH2-NH2" " |" " OH" "040/" """クロロホルム／メタノール(2:1,V/V)に可溶 (040)""" "040/" "C-P結合の特徴的な吸収てある 1080から 1050cm-1へ，1240から 1200cm-1へのシフ トがみられる。 (040)" "040/" """テトラヒメナ(040),ゾウリムシ(041)""" "040/041/" """1,2-DIACYL-SN-GLYCERYL-(3)-2'-AMINOETHYLPHOSPHONATE""" "GLYCEROPHOSPHONOLIPID" 41.00 80.00 7.00 1.00 1.00 729.00 " CH2-O-CO(CH2)16CH33 (REF:042)" " |" " CH3-(CH2)7-CH=CH-(CH2)7-CO-OCH O" " | ｾ" " CH2-O-P-CH2-CH2-NH2" " |" " OH" "042/" """クロロホルム／メタノール(2:1,V/V)に可溶 (042)""" "042/" """エステル C=O 1730, C-P結合 1190cm-1 の特徴的なピークが示されている。(042)""" "042/" """テトラヒメナ(042/043),ゾウリムシ(041),ウシ胆汁(044)""" "042/043/044/" "CHOLYL2-AMINOETHYLPHOSPHONIC ACID" "CILIATOCHLIC ACID" 26.00 46.00 7.00 1.00 1.00 515.00 " (REF:045)" " HO ＼／＼ O" " ﾅ ｵ ｵ ｾ" " ／＼ｫ＼ CO-NH-CH2-CH2-O-P-OH" " ｵｶｽｺ |" " ／＼ｫ＼／ OH" " ｵ ｵ ｵ" " ﾄ＼／＼／ﾅ" " HO OH" "045/" "145-146ﾟC ( )" """エタノールおよびクロロホルム／メタノール(2:1,V/V)に可溶 (045)""" "045/" "1630と 1545cm-1の酸アミドの吸収あり。 COO-に基づく 1720cm-1の吸収は無い。 (045)" "045/" "ウシの胆汁 (045)" "045/" "GAL3MEβ1→3GALNACα1→3[6'-O-(2-AMINOETHYLPHOSPHONYL)GALα1→2](2-AMINO- ETHYLPHOSPHONYL→6)GALβ1-4GLCβ1-1CERAMIDE" "PHOSPHONOGLYCOLIPID" "SGL-II" 71.00 133.00 32.00 4.00 2.00 1615.00 " (REF:046)" " 2-AEP" " |" " 6" " G3alβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " 3 2" " | |ｯ" " Me 2-AEP-6Galα1" "046/" """クロロホルム／メタノール／水(30:60:10,V/V)に可溶 (046)""" "046/" "構成糖のアノマー分析が 200または 400MHzによるスペクトルでなされた。(046)" """陽イオン FAB/MSで分子量イオンが測定されるが,糖鎖配列の情報は得られない。 (046)""" "046/" "アメフラシ(046/047)" "046/047/" "神経組織にSGL-IIが存在することを免疫化学的手法で証明(048)" "048/" "アメフラシの PHOSPHONOGLYCOLIPIDS( C-P糖脂質類 )の２次元 TLC による分析 (049)" "049/" "GlcNAc4MEα1→4GalNAcα1→3[6'-O-(2-AMINOETHYLPHOSPHONYL)Galα1→2](2-AMINOETHYLPHOSPHONYL→6)Galβ1-4(2-AMINOETHYLPHOSPHONYL→6)Glcβ1-1CER" "PHOSPHONOGLYCOLIPID" "SGL-I" 75.00 142.00 34.00 6.00 3.00 1615.00 " (REF:050)" " 2-AEP 2-AEP" " | |" " 6 6" " GlcNAc1-4α1-4GalNAcα1-3Galβ1-4Glcβ1-1CER" " 4 2" " | |ｯ" " Me 2-AEP-6Galα1" "050/" """クロロホルム／メタノール／水(60:35:8,V/V)に可溶 (050)""" "050/" "PMRによって構成糖のアノマー配置を分析(050)" "陽イオン FAB/MSによって分子量イオンが検出された。4-O-METHYLGLUCOSAMINEを部分メチル化アルジトール誘導体としGC/MSで同定した。 (050)" "050/" "アメフラシ(050)" "050/" "Gal3MEβ1→3GalNAcα1→3[6'-O-(2-AMINOETHYLPHOSPHONYL)Galα1→2]Galβ1- -4Glcβ1-1CERAMIDE" "PHOSPHONOGLYCOLIPID" "SGL-I'" 69.00 127.00 30.00 3.00 1.00 1508.00 " (REF:051)" " Galβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " 3 2" " | |ｯ" " Me 2-AEP-6Galα1" "051/" """クロロホルム／メタノール／水(60:35:8,V/V)に可溶 (051)""" "051/" "構成糖のアノマーを PMR で分析(051)" "ANTEISO-NONADECA-4-SPHINGENINEをANTEISOPEPTADECENALに誘導しGC/MSで同定した (051)" "051/" "アメフラシ(051)" "051/" """[3,4-O-CARBOXYETHYLIDENE)]Galβ1→3GalNAcα1→3(Fucα1→2)(2-AMINOETHYLPHOSPHONYL→6)Galβ1-4Glcβ1-1CERAMIDE""" "PHOSPHONOGLYCOSPHINGOLIPID" "FGL-IIB" 37.00 63.00 28.00 2.00 1.00 1014.00 " (REF:052)" " 2-AEP" " HOOC O |" " ﾅ ／ ＼4 6" " C Galβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " ﾄ ＼ ／3 2" " H3C O |ｯ" " Fucα1" "052/" """クロロホルム／メタノール／水(60:35:8,V/V)に可溶 (052)""" "052/" "PMRによって構成糖のアノマー配置を分析(052)" "陰イオンFAB/MSによって分子量イオンおよび糖配列を分析 (052)" "052/" "アメフラシの神経系(052)" "052/" "6'-O-(N-METHYL-2-AMINOETHYLPHOSPHONYL)GLUCOSYL1-1CERAMIDE" "PHOSPHONOCEREBROSIDE" 49.00 91.00 11.00 2.00 1.00 914.00 " OH (REF:039)" " |" " CH3-NH-CH2-CH2-P-O-6Glc-O-CH2-CH-CH-CH=CH-C13H23" " ｾ | |" " O NH OH" " |" " CO" " |" " CHOH" " ｯ C20H39" "039/" """クロロホルム／メタノール(2:1,V/V)およびクロロホルム／メタノール／水 (10:10:1,V/V/V)に可溶 (039)""" "039/" """OHの吸収 3400cm-1, アミド I およびアミド II の吸収 1640と1550cm-1, C-P結合の吸収 1200cm-1(039)""" "1H-NMR (039)" "FAB-MS: NEGATIVE FAB-MSで[M-H]- 913M/ZとN-METHYL-Z-AMINOETHYLPHOSPHONATEの 138 M/Zが検出できる。(039)" "039/" "オキアミ，テナガエビなどエビ類 (039)" "039/" "GALACTOSYLα1-2GALACTOCYLβ1-4(2-AMINOETHYLPHOSPHONYL1-6)GLUCOCYLβ1-1CERAMIDE" "PHOSPHONOGLYCOSPHINGOLIPID" "AJPnGL" 55.00 105.00 20.00 2.00 1.00 0.00 0.00 " 2-AEPn (REF:053)" " |" " 6" " Galα1-2Galβ1-4Glcβ1-1CER" " CER: MAIN FATTY ACID = 16:0" " MAIN LCB = BR D19:1" "053/" "クロロホルム／メタノール／水(60:35:5)に可溶(053)" "053/" "1H-NMRによってアノマー配置を決定(053)" "正イオンおよび負イオンFAB/MSで構成成分の結合順序を解析し分子量を測定。(053)" "053/" "アマクサアメフラシ(APLYSIA JULIANA)の卵 (053)" "053/" "3-O-METHYLGALACTOSYLα1-3-N-ACETYLGALCTOSAMINYLα1-3[6'-0-(2-AMINOETHYLPHOSPHONYL)GALACTOSYLα1-2]GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE" "PHOSPHONOGLYCOSPHINGOLIPID" "PnGSL-2" 69.00 130.00 31.00 3.00 1.00 0.00 0.00 " (REF:054)" " Galα1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " 3 2" " | |" " Me 2-AEPn-6Galα1" " CER : MAIN FATTY ACID = 16:0" " MAIN LCB = D18:1" "054/" "クロロホルム／メタノール／(2:1)(054)" "054/" "1H-NMRによって糖のアノマー配置を決定(054)" "正イオンおよび負イオン FAB/MS で構成成分の結合順序と分子量を測定。(054)" "054/" "タツナミガイ(DOLABELLA AURICULARIA) (054)" "054/" "3-0-METHYLGALACTOSYLα1-3(6'-O-[2-AMINOETHYLPHOSPHONYL)GALACTOSYLα1-2]GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE" "PHOSPHONOGLYCOSPHINGOLIPID" "PnGSL-1" 61.00 115.00 25.00 2.00 1.00 0.00 0.00 " (REF:054)" " 2-AEPn-6Galα1" " |" " 2" " Galα1-3Galβ1-4Glcβ1-1CER" " 3" " | CERAMIDE: MAIN FATTY ACID =16:0" " Me MAIN LCB = D18:1" "054/" "クロロホルム／メタノール／(2:1)に可溶(054)" "054/" "1H-NMRによって糖のアノマー配置を決定(054)" "正イオンおよび負イオン FAB/MS で構成成分の結合順序と分子量を測定。(054)" "054/" "タツナミガイ(DOLABELLA AURICULARIA) (054)" "054/" """[3,4-O-(S-1-CARBOXYETHYLIDENE)]GALACTOSYLβ1-3-N-ACETYLGALACTOSAMINYLα1-3[6'-O-(2-AMINOETHYLPHOSPHONYL)-GALACTOSYLα1-2](2-AMINOETHYLPHOSPHONYL1→6)GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE""" "PHOSPHONOGLYCOSPHINGOLIPID" "FGL-V" 74.00 136.00 34.00 4.00 2.00 0.00 0.00 " 2-AEPn (REF:055)" " H3C O |" " ﾒ ／ ＼4 6" " C Galβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " ﾄ ＼ ／3 2" " HOOC O |" " 2-AEPn-6Galα1" "055/" "クロロホルム／メタノール／水(60:35:8)および1-プロパール／水(7:3)に可溶(055)" "055/" "1H-NMRによって糖のアノマー配置を決定。 COSY スペクトルによってピルビン酸の結合位置を解析。(055)" "FAB/MS によって分子量を測定し、構成成分の結合順序を解析。(055)" "055/" "アメフラシの神経系 (055)" "055/" """[3,4-O-(S-1-CARBOXYETHYLIDENE)]GALACTOSYLβ1-3-N-ACETYLGALACTOSAMINYLα1-3[6'-O-(2-AMINOETHYLPHOSPHONYL)-GALACTOSYLα1-2]GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE""" "PHOSPHONOGLYCOSPHINGOLIPID" "FGL-IIa" 72.00 130.00 32.00 3.00 1.00 0.00 0.00 " (REF:055)" " H3C O" " ﾒ ／ ＼4" " C Galβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " ﾄ ＼ ／3 2" "HOOC O |" " 2-AEPn-6Galα1" "055/" "クロロホルム／メタノール／水(60:35:8)および1-プロパール／水(7:3)に可溶(055)" "055/" "1H-NMRによって糖のアノマー配置を決定。 COSY スペクトルでピルビン酸の結合位置を解析。(055)" "FAB/MS によって分子量を測定し、構成成分の結合順序を解析。(055)" "055/" "アメフラシの神経系 (055)" "055/" "3-O-METHYLGALACTOSYLβ1-3(2-AMINOETHYLPHOSPHONYL1-6)N-ACETYLGALACTOSAMINYL α1-3[6'-O-(2-AMINOETHYLPHOSPHONYL)-GALACTOSYLα1-2](2-AMINOETHYLPHOSPHOYL1-6)GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE" "PHOSPHONOGLYCOSPHINGOLIPID" "F-21" 74.00 142.00 34.00 2.00 1.00 0.00 0.00 " 2-AEPn 2-AEPn (REF:056)" " | |" " 6 6" " Galβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " 3 2" " | |" " Me 2-AEPn-6Galα1" "056/" "クロロホルム／メタノール／水(65:35:5)および1-プロパール／水(7:3)に可溶(056)" "056/" "1H-NMRによって糖のアノマー配置を分析。(056)" "FAB/MS によって構成成分の結合順序を解析。(056)" "056/" "アメフラシの神経系 (056)" "056/" """[3,4-O-(S-1-CARBOXYETHYLIDENE)]GALACTOSYLβ1-3N-ACETYLGALACTOSAMINYLα1-3[6'-O-(2-AMINOETHYLPHOSPHONYL)-GALACTOSYLα1-2](2-AMINOETHYLPHOSPHORYL1-6)GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE""" "PHOSPHONOGLYCOSPHINGOLIPID" "F-9" 78.00 140.00 37.00 3.00 1.00 0.00 0.00 " AEPr (REF:057)" " H3C O |" " ﾒ ／ ＼4 6" " C Galβ1-3GalNAcα1-3Galβ1-4Glcβ1-1CER" " ﾄ ＼ ／3 2" " HOOC O |" " 2-AEPn-6Galα1" "057/" "1-プロパール／濃アンモニア水／水(75:5:20 - 65:10:20)に可溶(057)" "057/" "1H-NMRによって糖のアノマー配置を解析。(057)" "FAB/MS によって分子量を測定し，構成成分の結合順序を解析。(057)" "057/" "アメフラシの神経系 (057)" "057/" """[3,4-O-(S-1-CARBOXYETHYLIDENE)]GALACTOSYLβ1-3-N-ACETYLGALACTOSAMINYLα1-3(FUCOSYLα1-2)(2-AMINOETHYLPHOSPHOYL1-6)GALACTOSYLβ1-4GLUCOSYLβ1-1CERAMIDE""" "PHOSPHONOGLYCOSPHINGOLIPID" "FGL-1" 72.00 130.00 32.00 3.00 1.00 0.00 0.00 " 2-AEPr (REF:057)" " H3C O |" " ﾒ ／ ＼4 6" " C Galβ1-3GalNAcα1-3Galβ1-4Glcβ1→1CER" " ﾄ ＼ ／3 2" " HOOC O |" " Fucα1" "057/" "1-プロパノール／濃アンモニア水／水(75:5:20 - 65:10:20)に可溶(057)" "057/" "1H-NMRによって糖のアノマー配置を解析。(057)" "FAB/MS によって分子量を測定し，構成成分の結合順序を解析。(057)" "057/" "アメフラシの神経系 (057)" "057/" "4-HEXADECAPRENYL-1-DIHYDROPRENYL PHOSPHATE　/　DIHYDROHEPTADECAPRENYL PHOSPHATE" "DOLICHYL PHOSPHATE" 85.00 141.00 4.00 1.00 " O (REF:024/025)" " ｾ" " ｵ ｵ ｵ ｵ ｶ CH2-O-P-OH" " ／ｸ／＼／ｸ／＼／ｸ／＼／ｸ ／＼／ |" " ＼ｽ／ OH" " ｶｽｽｽｽｵ" " n=13" "024/025/" "3400, 2965, 2930, 2860, 1730, 1660, 1450, 1376, 1070, 835cm-1(029)" "029/" "ヒト肝臓, 心臓, 肺, 脾臓, 腎臓(031)" "031/" "N型糖鎖結合タンパクの糖鎖供与体 GPIアンカーの糖鎖供与体 細菌におけるO−マンノース化の供与体 (024/032)" "024/032/" "4-HEPTADECAPRENYL-1-DIHYDROPRENYL PHOSPHATE　/　DIHYDROOCTADECAPRENYL PHOSPHATE" "DOLICHYL PHOSPHATE" 90.00 149.00 4.00 1.00 " O (REF:024/025)" " ｾ" " ｵ ｵ ｵ ｵ ｶ CH2-O-P-OH" " ／ｸ／＼／ｸ／＼／ｸ／＼／ｸ ／＼／ |" " ＼ｽ／ OH" " ｶｽｽｽｽｵ" " n=14" "024/025/" "3400, 2965, 2930, 2860, 1730, 1660, 1450, 1376, 1070, 835cm-1(029)" "029/" "ヒト肝臓, 心臓, 肺, 脾臓, 腎臓(031)" "031/" "N型糖鎖結合タンパクの糖鎖供与体 GPIアンカーの糖鎖供与体 細菌におけるO-マンノース化の供与体 (024/032)" "024/032/" "4-OCTADECAPRENYL-1-DIHYDROPRENYL PHOSPHATE / DIHYDRONONADECAPRENYL PHOSPHATE" "DOLICHYL PHOSPHATE" 95.00 157.00 4.00 1.00 " O (REF:024/025)" " ｾ" " ｵ ｵ ｵ ｵ ｶ CH2-O-P-OH" " ／ｸ／＼／ｸ／＼／ｸ／＼／ｸ ／＼／ |" " ＼ｽ／ OH" " ｶｽｽｽｽｵ" " n=15" "024/025/" "3400, 2970, 2930, 2860, 1720, 1665, 1450, 1380, 1215, 1070, 835cm-1(030)" "ドリコールとスペクトルが似ているが3.58ppmのピークがない｡(030)" "030/" "ヒト肝臓, 心臓, 肺, 脾臓, 腎臓(031)" "031/" "N型糖鎖結合タンパクの糖鎖供与体 GPIアンカーの糖鎖供与体 細菌におけるO-マンノース化の供与体 (024/032)" "024/032/" "4-NONADECAPRENYL-1-DIHYDROPRENYL PHOSPHATE-DIHYDROEICOSAPRENYL PHOSPHATE" "DOLICHYL PHOSPHATE" 100.00 165.00 4.00 1.00 " O (REF:024/025)" " ｾ" " ｵ ｵ ｵ ｵ ｶ CH2-O-P-OH" " ／ｸ／＼／ｸ／＼／ｸ／＼／ｸ ／＼／ |" " ＼ｽ／ OH" " ｶｽｽｽｽｵ" " n=16" "024/025/" "3400, 2965, 2930, 2860, 1730, 1660, 1450, 1376, 1070, 835cm-1(029)" "029/" "ヒト肝臓, 心臓, 肺, 脾臓, 腎臓(031)" "031/" "N型糖鎖結合タンパクの糖鎖供与体 GPIアンカーの糖鎖供与体 細菌におけるO-マンノース化の供与体 (024/032)" "024/032/" "4-ICOSAPRENYL-1-DIHYDROPRENYL PHOSPHATE / DIHYDROHEN(E)ICOSAPRENYL PHOSPHATE" "DOLICHYL PHOSPHATE" 105.00 173.00 4.00 1.00 " O (REF:024/025)" " ｾ" " ｵ ｵ ｵ ｵ ｶ CH2-O-P-OH" " ／ｸ／＼／ｸ／＼／ｸ／＼／ｸ ／＼／ |" " ＼ｽ／ OH" " ｶｽｽｽｽｵ" " n=17" "024/025/" "3400, 2965, 2930, 2860, 1730, 1660, 1450, 1376, 1070, 835cm-1(029)" "029/" "ヒト肝臓, 心臓, 肺, 脾臓, 腎臓(031)" "031/" "N型糖鎖結合タンパクの糖鎖供与体 GPIアンカーの糖鎖供与体 細菌におけるO-マンノース化の供与体 (024/032)" "024/032/"